Open Access
ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Paulus Kirchhof,Stefano Bernussi,Dipak Kotecha,Hein Heidbuchel +3 more
- Vol. 70, Iss: 1, pp 1-84
About:
The article was published on 2017-01-01 and is currently open access. It has received 3603 citations till now. The article focuses on the topics: Management of atrial fibrillation.read more
Citations
More filters
Journal ArticleDOI
Evidence for Inflammation as a Driver of Atrial Fibrillation.
Xiaoxu Zhou,Samuel C. Dudley +1 more
TL;DR: The roles of inflammation in the occurrence, development, and mechanisms of AF are reviewed and the therapeutic implications of the correlation of inflammation and AF are reviews.
Journal ArticleDOI
In-hospital mortality of patients with atrial arrhythmias: insights from the German-wide Helios hospital network of 161 502 patients and 34 025 arrhythmia-related procedures
Sebastian König,Laura Ueberham,Ekkehard Schuler,Michael Wiedemann,Christopher Reithmann,Melchior Seyfarth,Armin Sause,Jürgen Tebbenjohanns,Anja Schade,Dong-In Shin,Alexander Staudt,Udo Zacharzowsky,Rene Andrie,Ulrike Wetzel,Hans Neuser,Carsten Wunderlich,Ralf Kuhlen,Jan G.P. Tijssen,Gerhard Hindricks,Andreas Bollmann +19 more
TL;DR: In-hospital mortality rates of patients with atrial arrhythmias in a German-wide, multi-centre administrative dataset allows feasible, comparable, and up-to-date performance measurement of clinically important endpoints in a real-world setting which may contribute to quality management programs and towards value-based healthcare.
Journal ArticleDOI
Combining Watchman left atrial appendage closure and catheter ablation for atrial fibrillation: multicentre registry results of feasibility and safety during implant and 30 days follow-up
Karen P. Phillips,Evgeny Pokushalov,Aleksandr Romanov,Sergey Artemenko,Richard J Folkeringa,Tamas Szili-Torok,Gaetano Senatore,Kenneth M. Stein,Omar Razali,Nicole Gordon,Lucas V.A. Boersma +10 more
TL;DR: The outcomes from these international, multicentre registries support the feasibility and safety of performing combined procedures of ablation and Watchman LAAC for patients with non-valvular AF and high stroke risk.
Journal ArticleDOI
Cardiac arrhythmias in the emergency settings of acute coronary syndrome and revascularization: an European Heart Rhythm Association (EHRA) consensus document, endorsed by the European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Acute Cardiovascular Care Association (ACCA)
Zbigniew Kalarus,Jesper Hastrup Svendsen,Jesper Hastrup Svendsen,Davide Capodanno,Gheorghe-Andrei Dan,Elia De Maria,Bulent Gorenek,Ewa Jędrzejczyk-Patej,Michał Mazurek,Tomasz Podolecki,Christian Sticherling,Jacob Tfelt-Hansen,Jacob Tfelt-Hansen,Vassil Traykov,Gregory Y.H. Lip,Gregory Y.H. Lip,Laurent Fauchier,Giuseppe Boriani,Jacques Mansourati,Carina Blomström-Lundqvist,Georges H. Mairesse,Andrea Rubboli,Thomas Deneke,Nikolaos Dagres,Torkel Steen,Ingo Ahrens,Vijay Kunadian,Vijay Kunadian,Sergio Berti +28 more
TL;DR: The scope of this position document is to cover the clinical implications and pharmacological/non-pharmacological management of arrhythmias in emergency presentations and during revascularization.
Journal ArticleDOI
JCS/JHRS 2019 Guideline on Non-Pharmacotherapy of Cardiac Arrhythmias.
Akihiko Nogami,Takashi Kurita,Haruhiko Abe,Kenji Ando,Toshiyuki Ishikawa,Katsuhiko Imai,Akihiko Usui,Kaoru Okishige,Kengo Fukushima Kusano,Koichiro Kumagai,Masahiko Goya,Yoshinori Kobayashi,Akihiko Shimizu,Wataru Shimizu,Morio Shoda,Naokata Sumitomo,Yoshihiro Seo,Atsushi Takahashi,Hiroshi Tada,Shigeto Naito,Yuji Nakazato,Takashi Nishimura,Takashi Nitta,Shinichi Niwano,Nobuhisa Hagiwara,Yuji Murakawa,Teiichi Yamane,Takeshi Aiba,Koichi Inoue,Yuki Iwasaki,Yasuya Inden,Kikuya Uno,Michio Ogano,Masaomi Kimura,Shun-ichiro Sakamoto,Shingo Sasaki,Kazuhiro Satomi,Tsuyoshi Shiga,Tsugutoshi Suzuki,Yukio Sekiguchi,Kyoko Soejima,Masahiko Takagi,Masaomi Chinushi,Nobuhiro Nishi,Takashi Noda,Hitoshi Hachiya,Masataka Mitsuno,Takeshi Mitsuhashi,Yasushi Miyauchi,Aya Miyazaki,Tomoshige Morimoto,Hiro Yamasaki,Yoshifusa Aizawa,Tohru Ohe,Takeshi Kimura,Kazuo Tanemoto,Hiroyuki Tsutsui,Hideo Mitamura +57 more
TL;DR: The use of pacemaker treatment for bradyarrhythmia was first approved for national health insurance coverage in Japan in 1974, and its use rapidly became widespread thereafter as mentioned in this paper.
References
More filters
Journal ArticleDOI
2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).
Giuseppe Mancia,Robert Fagard,Krzysztof Narkiewicz,Josep Redon,Alberto Zanchetti,Michael Böhm,Thierry Christiaens,Renata Cifkova,Guy De Backer,Anna F. Dominiczak,Maurizio Galderisi,Diederick E. Grobbee,Tiny Jaarsma,Paulus Kirchhof,Sverre E. Kjeldsen,Stéphane Laurent,Athanasios J. Manolis,Peter M. Nilsson,Luis M. Ruilope,Roland E. Schmieder,Per Anton Sirnes,Peter Sleight,Margus Viigimaa,Bernard Waeber,Faiez Zannad,Michel Burnier,Ettore Ambrosioni,Mark Caufield,Antonio Coca,Michael H. Olsen,Costas Tsioufis,Philippe van de Borne,José Luis Zamorano,Stephan Achenbach,Helmut Baumgartner,Jeroen J. Bax,Héctor Bueno,Veronica Dean,Christi Deaton,Çetin Erol,Roberto Ferrari,David Hasdai,Arno W. Hoes,Juhani Knuuti,Philippe Kolh,Patrizio Lancellotti,Aleš Linhart,Petros Nihoyannopoulos,Massimo F Piepoli,Piotr Ponikowski,Juan Tamargo,Michal Tendera,Adam Torbicki,William Wijns,Stephan Windecker,Denis Clement,Thierry C. Gillebert,Enrico Agabiti Rosei,Stefan D. Anker,Johann Bauersachs,Jana Brguljan Hitij,Mark J. Caulfield,Marc De Buyzere,Sabina De Geest,Geneviève Derumeaux,Serap Erdine,Csaba Farsang,Christian Funck-Brentano,Vjekoslav Gerc,Giuseppe Germanò,Stephan Gielen,Herman Haller,Jens Jordan,Thomas Kahan,Michel Komajda,Dragan Lovic,Heiko Mahrholdt,Jan Östergren,Gianfranco Parati,Joep Perk,Jorge Polónia,Bogdan A. Popescu,Zeljko Reiner,Lars Rydén,Yuriy Sirenko,Alice Stanton,Harry A.J. Struijker-Boudier,Charalambos Vlachopoulos,Massimo Volpe,David A. Wood +89 more
TL;DR: In this article, a randomized controlled trial of Aliskiren in the Prevention of Major Cardiovascular Events in Elderly people was presented. But the authors did not discuss the effect of the combination therapy in patients living with systolic hypertension.
Journal ArticleDOI
Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment
Harold P. Adams,Birgitte H. Bendixen,L J Kappelle,José Biller,Betsy B. Love,David Lee Gordon,E. Eugene Marsh +6 more
TL;DR: The TOAST stroke subtype classification system is easy to use and has good interobserver agreement and should allow investigators to report responses to treatment among important subgroups of patients with ischemic stroke.
Journal ArticleDOI
Dabigatran versus warfarin in patients with atrial fibrillation
Stuart J. Connolly,Michael D. Ezekowitz,John W. Eikelboom,Jonas Oldgren,Amit Parekh,Janice Pogue,Paul A. Reilly,Ellison Themeles,Jeanne Varrone,Susan Wang,Marco Alings,Denis Xavier,Jun Zhu,Rafael Diaz,Basil S. Lewis,Harald Darius,Hans-Christoph Diener,Campbell D. Joyner,Lars Wallentin +18 more
TL;DR: In patients with atrial fibrillation, dabigatran given at a dose of 110 mg was associated with rates of stroke and systemic embolism that were similar to those associated with warfarin, as well as lower rates of major hemorrhage.
Journal ArticleDOI
Spontaneous Initiation of Atrial Fibrillation by Ectopic Beats Originating in the Pulmonary Veins
Michel Haïssaguerre,Pierre Jaïs,D. C. Shah,Atsushi Takahashi,Mélèze Hocini,G Quiniou,S. Garrigue,A Le Mouroux,P Le Métayer,Jacques Clementy +9 more
TL;DR: The pulmonary veins are an important source of ectopic beats, initiating frequent paroxysms of atrial fibrillation and these foci respond to treatment with radio-frequency ablation.
Journal ArticleDOI
Apixaban versus Warfarin in Patients with Atrial Fibrillation
Christopher B. Granger,John H. Alexander,Renato D. Lopes,Elaine M. Hylek,Michael G. Hanna,Hussein R. Al-Khalidi,Jack Ansell,Dan Atar,Alvaro Avezum,M. Cecilia Bahit,Rafael Diaz,J. Donald Easton,Justin A. Ezekowitz,Greg C. Flaker,David A. Garcia,Margarida Geraldes,Bernard J. Gersh,Sergey P. Golitsyn,Shinya Goto,Antonio G. Hermosillo,Stefan H. Hohnloser,John D. Horowitz,Puneet Mohan,Petr Jansky,Basil S. Lewis,Jose Lopez-Sendon,Prem Pais,Alexander Parkhomenko,Jun Zhu,Lars Wallentin +29 more
TL;DR: In patients with atrial fibrillation, apixaban was superior to warfarin in preventing stroke or systemic embolism, caused less bleeding, and resulted in lower mortality.
Related Papers (5)
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS: The Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Endorsed by the European Stroke Organisation (ESO)
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Paulus Kirchhof,Stefano Benussi,Dipak Kotecha,Anders Ahlsson,Dan Atar,Barbara Casadei,Manuel Castellá,Hans-Christoph Diener,Hein Heidbuchel,Jeroen M.L. Hendriks,Gerhard Hindricks,Antonis S. Manolis,Jonas Oldgren,Bogdan A. Popescu,Ulrich Schotten,Bart P. Van Putte,Panagiotis Vardas,Stefan Agewall,John Camm,Gonzalo Barón Esquivias,Werner Budts,Scipione Carerj,Filip Casselman,Antonio Coca,Raffaele De Caterina,Spiridon Deftereos,Dobromir Dobrev,José M. Ferro,Gerasimos Filippatos,Donna Fitzsimons,Bulent Gorenek,Maxine Guenoun,Stefan H. Hohnloser,Philippe Kolh,Gregory Y.H. Lip,Athanasios J. Manolis,John J.V. McMurray,Piotr Ponikowski,Raphael Rosenhek,Frank Ruschitzka,Irina Savelieva,Sanjay Sharma,Piotr Suwalski,Juan Tamargo,Clare J Taylor,Isabelle C. Van Gelder,Adriaan A. Voors,Stephan Windecker,José Luis Zamorano,Katja Zeppenfeld +49 more